Heart failure & cardiomyopathies

Proteomic Biomarkers and Pathway Analysis for Progression to Heart Failure in Three Epidemiological Representative Cohorts

Eur J Heart FailPublished Prospective cohort study

Authors' conclusion

In conclusion, our study reinforces the role of NT-proBNP as a key biomarker for asymptomatic cardiac dysfunction and incident HF, consistent with its established use in clinical practice.

Study context

Population
Population-based cohorts; association of 92 proteomic biomarkers with left ventricular hypertrophy (LVH), diastolic dysfunction and incident heart failure (HF)three cohorts
Exposure
Malmö Preventive Project (MPP) vs STANISLAS vs HOMAGE
Outcome
LVH, diastolic dysfunction (DD) and incident HF
Follow-up
Median 13 (11-14) years (MPP)
Methodological detailsthree population-based cohorts, case-control (HOMAGE), proteomic chip of 92 biomarkers
  • Three population-based cohorts
  • Case-control (HOMAGE)
  • Proteomic chip of 92 biomarkers

Main finding

As reported in the abstract

NT-proBNP association with LVH, DD and incident HF
Estimate (95% CI)
MPPNT-proBNP, LVH
OR 1.48(1.28–1.71)
MPPNT-proBNP, DD
OR 1.71(1.53–1.92)
MPPNT-proBNP, incident HF
HR 1.98(1.66–2.36)
STANISLASNT-proBNP, LVH
OR 1.20(1.02–1.41)
STANISLASNT-proBNP, DD
OR 1.46(1.12–1.90)
HOMAGENT-proBNP, incident HF
HR 1.85(1.62–2.12)

Observational data: associations, not effects.

Further findings

Outcome frequencies in MPP · median follow-up 13 (11-14) years

LVH
514 (34%)
Diastolic dysfunction (DD)
462 (32.4%)
Incident HF
130 (7.7%)

Outcome frequencies in STANISLAS

LVH
238
DD
76

Other biomarkers and incident HF

Galectin-4, GDF-15 and ST2 associated with incident HF in MPP and HOMAGE
Pathway enrichment suggested inflammation and viral infection related to incident HF

Original publication

Proteomic Biomarkers and Pathway Analysis for Progression to Heart Failure in Three Epidemiological Representative Cohorts. Eur J Heart Fail. Published 28 October 2024. doi:10.1002/ejhf.3502

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.